Literature DB >> 28709633

Treatment and Nontreatment of the Patent Ductus Arteriosus: Identifying Their Roles in Neonatal Morbidity.

Ronald I Clyman1, Melissa Liebowitz2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28709633      PMCID： PMC5639904          DOI： 10.1016/j.jpeds.2017.06.054

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  52 in total

1.  Patent ductus arteriosus and its treatment as risk factors for neonatal and neurodevelopmental morbidity.

Authors:  Nancy Chorne; Carol Leonard; Robert Piecuch; Ronald I Clyman
Journal:  Pediatrics       Date:  2007-06       Impact factor: 7.124

Review 2.  The definition of a haemodynamic significant duct in randomized controlled trials: a systematic literature review.

Authors:  Inge Zonnenberg; Koert de Waal
Journal:  Acta Paediatr       Date:  2011-10-06       Impact factor: 2.299

3.  Recommendations for the postnatal use of indomethacin: an analysis of four separate treatment strategies.

Authors:  R I Clyman
Journal:  J Pediatr       Date:  1996-05       Impact factor: 4.406

Review 4.  Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants.

Authors:  Peter W Fowlie; Peter G Davis; William McGuire
Journal:  Cochrane Database Syst Rev       Date:  2010-07-07

5.  Effect of patent ductus arteriosus on water accumulation and protein permeability in the lungs of mechanically ventilated premature lambs.

Authors:  G Alpan; F Mauray; R I Clyman
Journal:  Pediatr Res       Date:  1989-12       Impact factor: 3.756

6.  Trends and variation in management and outcomes of very low-birth-weight infants with patent ductus arteriosus.

Authors:  James I Hagadorn; Elizabeth A Brownell; Jennifer M Trzaski; Kendall R Johnson; Shabnam Lainwala; Brendan T Campbell; Katherine W Herbst
Journal:  Pediatr Res       Date:  2016-08-10       Impact factor: 3.756

7.  Effects of patent ductus arteriosus on left ventricular output and organ blood flows in preterm infants with respiratory distress syndrome treated with surfactant.

Authors:  S Shimada; T Kasai; M Konishi; T Fujiwara
Journal:  J Pediatr       Date:  1994-08       Impact factor: 4.406

8.  The role of patent ductus arteriosus ligation in bronchopulmonary dysplasia: reexamining a randomized controlled trial.

Authors:  Ronald Clyman; George Cassady; James K Kirklin; Monica Collins; Joseph B Philips
Journal:  J Pediatr       Date:  2009-03-25       Impact factor: 4.406

9.  Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study.

Authors:  W M Gersony; G J Peckham; R C Ellison; O S Miettinen; A S Nadas
Journal:  J Pediatr       Date:  1983-06       Impact factor: 4.406

Review 10.  Indomethacin for asymptomatic patent ductus arteriosus in preterm infants.

Authors:  L Cooke; P Steer; P Woodgate
Journal:  Cochrane Database Syst Rev       Date:  2003
View more
  6 in total

1.  Neurodevelopment at 5 Years of Age According to Early Screening for Patent Ductus Arteriosus in Extremely Preterm Infants.

Authors:  Gilles Cambonie; Jean-Christophe Rozé; Laetitia Marchand-Martin; Stéphane Marret; Xavier Durrmeyer; Héloïse Torchin; Pierre-Yves Ancel
Journal:  JAMA       Date:  2022-07-05       Impact factor: 157.335

2.  Spontaneous closure of patent ductus arteriosus in preterm babies after failed attempts at transcatheter device closure.

Authors:  Ahmed Deniwar; Matthew Brown; Duraisamy Balaguru
Journal:  Ann Pediatr Cardiol       Date:  2022-08-19

Review 3.  Patent ductus arteriosus in preterm infants: is early transcatheter closure a paradigm shift?

Authors:  P Vali; S Lakshminrusimha; A Pelech; M Underwood; F Ing
Journal:  J Perinatol       Date:  2019-09-27       Impact factor: 3.225

4.  A Matched Case Control Study of Surgically and Non-surgically Treated Patent Ductus Arteriosus in Extremely Pre-term Infants.

Authors:  Karl Wilhelm Olsson; Sawin Youssef; Mattias Kjellberg; Renske Raaijmakers; Richard Sindelar
Journal:  Front Pediatr       Date:  2021-03-18       Impact factor: 3.418

5.  Early N-Terminal Pro B-Type Natriuretic Peptide (NTproBNP) Plasma Values and Associations with Patent Ductus Arteriosus Closure and Treatment-An Echocardiography Study of Extremely Preterm Infants.

Authors:  Anna Gudmundsdottir; Marco Bartocci; Oda Picard; Joanna Ekström; Alexander Chakhunashvili; Kajsa Bohlin; Caroline Attner; Gordana Printz; Mathias Karlsson; Lilly-Ann Mohlkert; Jonna Karlén; Cecilia Pegelow Halvorsen; Anna-Karin Edstedt Bonamy
Journal:  J Clin Med       Date:  2022-01-27       Impact factor: 4.241

6.  Rates of Bronchopulmonary Dysplasia Following Implementation of a Novel Prevention Bundle.

Authors:  Maria Fe B Villosis; Karine Barseghyan; Ma Teresa Ambat; Kambiz K Rezaie; David Braun
Journal:  JAMA Netw Open       Date:  2021-06-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.